Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapy.
Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapy.
复制标题
通过 ROS 敏感的 c-Myc 靶向治疗干预 Caveolin-1 相关的细胞间通讯来拦截肿瘤进展。
DOI:
10.1016/j.biomaterials.2021.120958
复制
发表时间:
2021-06
期刊:
影响因子:
14
通讯作者:
Fuqiang Hu
中科院分区:
文献类型:
--
作者:
Xueqing Zhou;Xuan Liu;Xiqin Yang;Li Wang;Xuwei Shang;Zhongjun Ma;Yiling Hong;Keke Lian;Guoxi Qiu;Hong Yuan;Fuqiang Hu
Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) play an important role in the development of tumors by secreting a variety of cytokines or directly communicating with tumor cells, making TAMs-targeted therapeutic strategies very attractive. It has been reported that oncogenec-Mycis related to every aspect of the oncogenic process of tumor cells and the alternative activation of macrophages. Hence, we constructed a glycolipid nanocarrier containing ROS-responsive peroxalate linkages (CSOPOSA) for ROS-triggered release of drugs and further modified it with Ex 26 (Ex 26-CSOPOSA), a selective sphingosine 1-phosphate receptor 1 (S1PR1) antagonist, to achieve the dual-targeted delivery of thec-Mycinhibitor JQ1viaS1PR1, which is overexpressed on both tumor cells and TAMs, thereby inducing apoptosis of tumor cells, and blocking M2 polarization of macrophages. More strikingly, our studies found that JQ1 could effectively inhibit the migration of tumor cells induced by M2 macrophages-derived exosomesviablocking Caveolin-1 related intercellular exosome exchange through lncRNA H19 and miR-107. Thein vivoresults revealed that this dual-targeted delivery strategy effectively inhibited tumor growth and metastasis with less systemic toxicity, providing a potential method for effective tumor treatment.
登录
查看更多内容
DOI:
10.1126/science.aac9935
发表时间:
2016-04-08
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Casey SC;Tong L;Li Y;Do R;Walz S;Fitzgerald KN;Gouw AM;Baylot V;Gütgemann I;Eilers M;Felsher DW
通讯作者:
Felsher DW
影响因子:
8.8
作者:
Ino Y;Yamazaki-Itoh R;Shimada K;Iwasaki M;Kosuge T;Kanai Y;Hiraoka N
通讯作者:
Hiraoka N
影响因子:
10.8
作者:
Shi, Changrong;Liu, Ting;Chen, Xiaoyuan
通讯作者:
Chen, Xiaoyuan
DOI:
10.1038/nrclinonc.2016.217
发表时间:
2017-07
期刊:
Nature reviews. Clinical oncology
影响因子:
--
作者:
Mantovani A;Marchesi F;Malesci A;Laghi L;Allavena P
通讯作者:
Allavena P
影响因子:
16.6
作者:
Liu, Ze;Xiong, Min;Xiang, Rong
通讯作者:
Xiang, Rong